Conor MedSystems
Menlo Park
About Conor MedSystems
Conor MedSystems develops innovative controlled vascular drug delivery technologies. They have initially focused on the development of drug eluting stents to treat coronary artery disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Total funding: $38.0M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2003)
- Ticker: nasdaq:CONR
- Website: conormed.com
- Phone: +1 800-447-7585
Industries & Categories
Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/conor-medsystems-580428 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.